Document Detail


Synthetic human calcitonin in refractory Paget's disease of bone.
MedLine Citation:
PMID:  3111398     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fourteen patients with symptomatic and active Paget's disease of bone who had demonstrated resistance to parenteral synthetic salmon calcitonin, oral disodium etidronate, or both in combination were treated with parenteral synthetic human calcitonin. Eleven patients (79%) demonstrated clinical and chemical improvement for up to five years. Two patients received additional benefit with combined synthetic human calcitonin and etidronate disodium.
Authors:
R D Altman; B Collins-Yudiskas
Related Documents :
16704438 - Haematopoietic stem cell transplantation as primary therapy of sporadic adult burkitt l...
10922238 - Histopathologic features of the temporal bone in usher syndrome type i.
9855148 - Ophthalmic manifestations of fibrous dysplasia: a disease of children and adults.
10829908 - Hematological manifestations of congenital cytomegalovirus infection.
15191918 - Enhanced monocyte chemoattractant protein-3/cc chemokine ligand-7 in usual interstitial...
24304538 - Soluble st2 and n-terminal pro-brain natriuretic peptide combination.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of internal medicine     Volume:  147     ISSN:  0003-9926     ISO Abbreviation:  Arch. Intern. Med.     Publication Date:  1987 Jul 
Date Detail:
Created Date:  1987-07-29     Completed Date:  1987-07-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372440     Medline TA:  Arch Intern Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1305-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Alkaline Phosphatase / blood
Calcitonin / administration & dosage,  therapeutic use*
Drug Therapy, Combination
Etidronic Acid / administration & dosage
Female
Hormones / administration & dosage,  therapeutic use*
Humans
Injections, Subcutaneous
Male
Middle Aged
Osteitis Deformans / drug therapy*
Chemical
Reg. No./Substance:
0/Hormones; 2809-21-4/Etidronic Acid; 9007-12-9/Calcitonin; EC 3.1.3.1/Alkaline Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modeling decisions to use tube feeding in seriously ill patients.
Next Document:  Euthyroid hyperthyroxinemia and inappropriate secretion of thyrotropin. Recognition and diagnosis.